Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Rangering i aksjer #27452
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Aksjekurs
$1.62
Sist synkronisert: 2026-08-19
Markedsverdi
$32.77M
Endring (1 dag)
22.67%
Endring (1 år)
-13.87%
Land
US
Handel AIxCrypto Holdings, Inc. (AIXC)

Kategori

Aksjeprishistorikk for AIxCrypto Holdings, Inc. (AIXC)
Høyeste sluttskurs: $0.90 den 2026-08-01

Laveste sluttskurs: $589.38K den 2015-06-01
Aksjeprishistorikk for AIxCrypto Holdings, Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$61.63 67.11%
US
$51.69 74.48%
SE
$196.55 45.91%
FR
$119.62 69.92%
US
$62.87 2.86%
IT